Building a Successful Fertility Preservation Program at a Major Cancer Center

Overview

Journal J Gynecol Oncol

Specialties Gynecology & Obstetrics
Oncology

Date 2014 Apr 25

PMID 24761219

Citations 6

Authors

Jayeon Kim

Kenneth H Kim

Jennifer E Mersereau

Affiliations

Soon will be listed here.

Abstract

Over 150,000 reproductive age individuals face fertility-threatening cancer treatments each year. Improved detection and treatment of cancer in reproductive-age patients have greatly increased the long-term survival and made it possible for these individuals to consider their long-term quality-of-life after cancer including having biologic offspring. Various methods of fertility preservation (FP) are now available for both males and females. In order to maximize FP options available to patients facing imminent gonadotoxic therapies, it is crucial that women have quick access to FP care and that providers expedite FP strategies. The overarching goal of a clinical FP program is to help patients and their physicians consider the impact of treatment on future fertility and facilitate FP efforts in what is often a limited time period before cancer treatment begins.

Citing Articles

Childbearing across borders: Fertility and parenthood attitudes and decisions among breast cancer survivors in USA and Portugal.

Goncalves V, Hudson J, Canavarro M, Morris J, Lee M, Donovan K Breast. 2018; 40:16-22.

PMID: 29674220 PMC: 6045956. DOI: 10.1016/j.breast.2018.04.001.

Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines.

Kim J, Kim S, Hwang K, Kim S Clin Exp Reprod Med. 2018; 44(4):171-174.

PMID: 29376012 PMC: 5783912. DOI: 10.5653/cerm.2017.44.4.171.

What is the Role of the Oncology Nurse in Fertility Preservation Counseling and Education for Young Patients?.

Keim-Malpass J, Fitzhugh H, Smith L, Smith R, Erickson J, Douvas M J Cancer Educ. 2017; 33(6):1301-1305.

PMID: 28667545 DOI: 10.1007/s13187-017-1247-y.

Preserving Fertility in Children and Adolescents with Cancer.

Levine J Children (Basel). 2016; 1(2):166-85.

PMID: 27417474 PMC: 4928722. DOI: 10.3390/children1020166.

Fertility preservation and cancer: challenges for adolescent and young adult patients.

Benedict C, Thom B, Kelvin J Curr Opin Support Palliat Care. 2016; 10(1):87-94.

PMID: 26730794 PMC: 4752165. DOI: 10.1097/SPC.0000000000000185.

References

Lowe M, Cooper B, Sood A, Davis W, Syrop C, Sorosky J . Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia. Gynecol Oncol. 2003; 91(3):569-72. DOI: 10.1016/j.ygyno.2003.08.007. View

Garvelink M, Ter Kuile M, Fischer M, Louwe L, Hilders C, Kroep J . Development of a Decision Aid about fertility preservation for women with breast cancer in The Netherlands. J Psychosom Obstet Gynaecol. 2013; 34(4):170-8. DOI: 10.3109/0167482X.2013.851663. View

Schover L, Brey K, Lichtin A, Lipshultz L, Jeha S . Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol. 2002; 20(7):1880-9. DOI: 10.1200/JCO.2002.07.175. View

Stacey D, Legare F, Col N, Bennett C, Barry M, Eden K . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014; (1):CD001431. DOI: 10.1002/14651858.CD001431.pub4. View

Kohler T, Kondapalli L, Shah A, Chan S, Woodruff T, Brannigan R . Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet. 2010; 28(3):269-77. PMC: 3082660. DOI: 10.1007/s10815-010-9504-6. View

Michie S, Dormandy E, Marteau T . The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns. 2002; 48(1):87-91. DOI: 10.1016/s0738-3991(02)00089-7. View

Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H . Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations. Eur J Gynaecol Oncol. 2001; 22(3):217-20. View

Goodman L, Balthazar U, Kim J, Mersereau J . Trends of socioeconomic disparities in referral patterns for fertility preservation consultation. Hum Reprod. 2012; 27(7):2076-81. PMC: 6457079. DOI: 10.1093/humrep/des133. View

Niwa K, Tagami K, Lian Z, Onogi K, Mori H, Tamaya T . Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG. 2005; 112(3):317-20. DOI: 10.1111/j.1471-0528.2004.00398.x. View

10.

Morice P, Rey A, Pautier P, Lhomme C, de Crevosier R, Haie-Meder C . Results of conservative treatment in epithelial ovarian carcinoma. Cancer. 2001; 92(9):2412-8. DOI: 10.1002/1097-0142(20011101)92:9<2412::aid-cncr1590>3.0.co;2-7. View

11.

Matthews M, Hurst B, Marshburn P, Usadi R, Papadakis M, Sarantou T . Cancer, fertility preservation, and future pregnancy: a comprehensive review. Obstet Gynecol Int. 2012; 2012:953937. PMC: 3316966. DOI: 10.1155/2012/953937. View

12.

Su H, Flatt S, Natarajan L, DeMichele A, Steiner A . Impact of breast cancer on anti-mullerian hormone levels in young women. Breast Cancer Res Treat. 2012; 137(2):571-7. PMC: 3540167. DOI: 10.1007/s10549-012-2361-5. View

13.

Manga G, Khosravi Shahi P, Urena M, Pereira R, Plaza M, Izarzugaza Peron Y . Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer. Breast Cancer. 2009; 17(3):205-11. DOI: 10.1007/s12282-009-0136-6. View

14.

Carlsen B, Aakvik A . Patient involvement in clinical decision making: the effect of GP attitude on patient satisfaction. Health Expect. 2006; 9(2):148-57. PMC: 5060341. DOI: 10.1111/j.1369-7625.2006.00385.x. View

15.

Duska L, Garrett A, Rueda B, Haas J, Chang Y, Fuller A . Endometrial cancer in women 40 years old or younger. Gynecol Oncol. 2001; 83(2):388-93. DOI: 10.1006/gyno.2001.6434. View

16.

Legare F, OConnor A, Graham I, Saucier D, Cote L, Cauchon M . Supporting patients facing difficult health care decisions: use of the Ottawa Decision Support Framework. Can Fam Physician. 2007; 52:476-7. PMC: 1481680. View

17.

Kim J, Oktay K . Baseline E(2) levels are higher in BRCA2 mutation carriers: a potential target for prevention?. Cancer Causes Control. 2012; 24(3):421-6. PMC: 3583585. DOI: 10.1007/s10552-012-0127-3. View

18.

Colombo N, Parma G, Lapresa M, Maggi F, Piantanida P, Maggioni A . Role of conservative surgery in ovarian cancer: the European experience. Int J Gynecol Cancer. 2005; 15 Suppl 3:206-11. DOI: 10.1111/j.1525-1438.2005.00428.x. View

19.

DAmour D, Ferrada-Videla M, Rodriguez L, Beaulieu M . The conceptual basis for interprofessional collaboration: core concepts and theoretical frameworks. J Interprof Care. 2005; 19 Suppl 1:116-31. DOI: 10.1080/13561820500082529. View

20.

Wang C, Wang C, Huang H, Hsueh S, Chou H, Soong Y . Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer. 2002; 94(8):2192-8. DOI: 10.1002/cncr.10435. View